Cetera Investment Advisers
IBB icon

Cetera Investment Advisers’s iShares Biotechnology ETF IBB Stock Holding History

Cetera Investment Advisers’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.7M Buy
128,530
+10,994
+9% +$1.88M 0.02% 646
2025
Q4 		$19.8M Buy
117,536
+56,888
+94% +$9.24M 0.02% 673
2025
Q3 		$8.76M Sell
60,648
-806
-1% -$110K 0.01% 1074
2025
Q2 		$7.77M Sell
61,454
-1,467
-2% -$180K 0.01% 950
2025
Q1 		$8.05M Sell
62,921
-2,384
-4% -$323K 0.02% 867
2024
Q4 		$8.63M Sell
65,305
-14,743
-18% -$2.07M 0.02% 774
2024
Q3 		$11.7M Sell
80,048
-11,371
-12% -$1.65M 0.03% 632
2024
Q2 		$12.5M Buy
91,419
+341
+0.4% +$45.5K 0.03% 582
2024
Q1 		$12.5M Buy
91,078
+79,541
+689% +$10.9M 0.03% 581
2023
Q4 		$1.57M Sell
11,537
-879
-7% -$107K 0.01% 890
2023
Q3 		$1.52M Sell
12,416
-2,005
-14% -$255K 0.01% 860
2023
Q2 		$1.83M Sell
14,421
-1,350
-9% -$175K 0.02% 808
2023
Q1 		$2.04M Sell
15,771
-13,403
-46% -$1.75M 0.02% 726
2022
Q4 		$3.83M Buy
29,174
+18,090
+163% +$2.34M 0.04% 472
2022
Q3 		$1.3M Sell
11,084
-13,950
-56% -$1.73M 0.03% 615
2022
Q2 		$2.94M Buy
25,034
+5,691
+29% +$676K 0.05% 402
2022
Q1 		$2.52M Sell
19,343
-2,773
-13% -$361K 0.04% 475
2021
Q4 		$3.38M Sell
22,116
-595
-3% -$92.1K 0.05% 391
2021
Q3 		$3.67M Sell
22,711
-357
-2% -$60.1K 0.06% 344
2021
Q2 		$3.77M Buy
23,068
+284
+1% +$43.7K 0.06% 334
2021
Q1 		$3.43M Buy
22,784
+1,049
+5% +$167K 0.07% 299
2020
Q4 		$3.29M Buy
21,735
+19,186
+753% +$2.74M 0.07% 306
2020
Q3 		$345K Sell
2,549
-2,802
-52% -$380K 0.03% 468
2020
Q2 		$731K Buy
5,351
+3,189
+148% +$407K 0.07% 292
2020
Q1 		$233K Sell
2,162
-290
-12% -$33.4K 0.03% 457
2019
Q4 		$295K Sell
2,452
-1,159
-32% -$129K 0.03% 455
2019
Q3 		$356K Sell
3,611
-685
-16% -$71.7K 0.04% 368
2019
Q2 		$469K Sell
4,296
-167
-4% -$17.8K 0.06% 308
2019
Q1 		$495K Buy
4,463
+203
+5% +$22.3K 0.07% 279
2018
Q4 		$405K Sell
4,260
-14
-0.3% -$1.49K 0.07% 287
2018
Q3 		$518K Sell
4,274
-135
-3% -$15.9K 0.07% 263
2018
Q2 		$483K Sell
4,409
-315
-7% -$33.7K 0.08% 248
2018
Q1 		$507K Buy
4,724
+73
+2% +$8.09K 0.09% 225
2017
Q4 		$500K Buy
4,651
+304
+7% +$32.5K 0.09% 243
2017
Q3 		$483K Buy
4,347
+312
+8% +$33.3K 0.11% 233
2017
Q2 		$423K Sell
4,035
-303
-7% -$29.8K 0.1% 249
2017
Q1 		$427K Buy
4,338
+1,215
+39% +$116K 0.12% 222
2016
Q4 		$278K Buy
+3,123
New +$284K 0.09% 250

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cetera Investment Advisers's IBB Position: Q1 2026 in Review

Cetera Investment Advisers increased its iShares Biotechnology ETF (IBB) stake by 9.4% in Q1 2026, buying an estimated $1.88M and bringing the position to 128,530 shares worth $21.7M. The position accounts for 0.02% of the portfolio, ranked #646.

Cetera Investment Advisers first reported a position in IBB in Q4 2016 and has held it in 38 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Cetera Investment Advisers held 128,530 shares of iShares Biotechnology ETF worth $21.7M as of Q1 2026.
  • Cetera Investment Advisers bought 10,994 iShares Biotechnology ETF shares in Q1 2026, an estimated $1.88M.
  • iShares Biotechnology ETF made up 0.02% of Cetera Investment Advisers's portfolio in Q1 2026, its #646 holding.
  • Cetera Investment Advisers first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 38 quarters since.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.